Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 4/2016

15.01.2016 | Original Article

Role of PPARG (Pro12Ala) in Malaysian type 2 diabetes mellitus patients

verfasst von: Darishiani Paramasivam, Sher Zaman Safi, Rajes Qvist, Imran Bin Zainal Abidin, Noran Naqiah Mohd Hairi, Karuthan Chinna

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Diabetes is one of the major lifestyle disorders in the world. Asian countries, including Malaysia, contribute with more than 60 % of the world’s diabetic population. The single nucleotide polymorphisms (SNPs) of the peroxisome proliferator-activated receptor gamma (PPARG) have been identified as one of the key regulators of glucose and lipid metabolism that controls the protein synthesis in multiple metabolic, biochemical, and molecular pathways. The aim of this study was to investigate the possible role of PPARG (Pro12Ala) gene polymorphism as a genetic risk factor for type 2 diabetes mellitus (T2DM) patients in Malaysian population. A total of 241 subjects between the age of 35 and 85 years were recruited in this study. Out of the total 241 subjects, 120 were T2DM patients and 121 were healthy individuals. SNP of PPARG (Pro12Ala) was determined by polymerase chain reaction (PCR) and restriction fragment length polymorphisms (RFLPs). The frequencies of wild homozygote (WH), heterozygote (H), and mutant homozygote (MH) among the T2DM patients were (n = 73) 60.8 %, (n = 39) 32.5 %, and (n = 3) 2.5 % compared to (n = 57) 47 %, (n = 46) 38 %, and (n = 16) 13.2 % among the healthy subjects. The mean of Hba1C (%) among normal and diabetic patients with genotypes were different (5.36 ± 0.54 vs 7.58 ± 1.76), p < 0.005. SNP of PPARG (Pro12Ala) gene could be a genetic risk factor for insulin resistance and T2DM among Malaysian population.
Literatur
1.
Zurück zum Zitat Ho MM, Yoganathan P, Chu KY, Karunakaran S, Johnson JD, Clee SM. Diabetes genes identified by genome-wide association studies are regulated in mice by nutritional factors in metabolically relevant tissues and by glucose concentrations in islets. BMC Genet. 2013;14(10):12. Ho MM, Yoganathan P, Chu KY, Karunakaran S, Johnson JD, Clee SM. Diabetes genes identified by genome-wide association studies are regulated in mice by nutritional factors in metabolically relevant tissues and by glucose concentrations in islets. BMC Genet. 2013;14(10):12.
3.
Zurück zum Zitat Safi SZ, Qvist R, Chinna K, Ashraf MA, Paramasivam D, Ismail IS. Gene expression profiling of the peripheral blood mononuclear cells of offspring of one type 2 diabetic parent. International Journal of Diabetes in Developing Countries. 2015. Safi SZ, Qvist R, Chinna K, Ashraf MA, Paramasivam D, Ismail IS. Gene expression profiling of the peripheral blood mononuclear cells of offspring of one type 2 diabetic parent. International Journal of Diabetes in Developing Countries. 2015.
4.
Zurück zum Zitat Garant MJ et al. SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: the atherosclerosis risk in communities study. Diabetes. 2002;51(1):231–7.CrossRefPubMed Garant MJ et al. SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: the atherosclerosis risk in communities study. Diabetes. 2002;51(1):231–7.CrossRefPubMed
5.
Zurück zum Zitat Safi SZ, Qvist R, Yan GO, Ismail IS. Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells. BMC Med Genet. 2014;7:29. doi:10.1186/1755-8794-7-29. Safi SZ, Qvist R, Yan GO, Ismail IS. Differential expression and role of hyperglycemia induced oxidative stress in epigenetic regulation of β1, β2 and β3-adrenergic receptors in retinal endothelial cells. BMC Med Genet. 2014;7:29. doi:10.​1186/​1755-8794-7-29.
6.
7.
Zurück zum Zitat Bermúdez V, Finol F, Parra N, Parra M, Pérez A, Peñaranda L, et al. FRCP Edin, PPAR-g agonists and their role in type 2 diabetes mellitus management. Am J Ther. 2010;17:274–83.CrossRefPubMed Bermúdez V, Finol F, Parra N, Parra M, Pérez A, Peñaranda L, et al. FRCP Edin, PPAR-g agonists and their role in type 2 diabetes mellitus management. Am J Ther. 2010;17:274–83.CrossRefPubMed
8.
Zurück zum Zitat Safi SZ, Shah H, Yan GO, Qvist R. Insulin resistance provides the connection between hepatitis C virus and diabetes. Hepat Mon. 2015;15(1), e23941.PubMed Safi SZ, Shah H, Yan GO, Qvist R. Insulin resistance provides the connection between hepatitis C virus and diabetes. Hepat Mon. 2015;15(1), e23941.PubMed
9.
10.
Zurück zum Zitat Safi SZ, Batumalaie K, Mansor M, Chinna K, Mohan S, Karimian H, et al. Glutamine treatment attenuates hyperglycemia-induced mitochondrial stress and apoptosis in umbilical vein endothelial cells. Clinics. 2015;70(8). Safi SZ, Batumalaie K, Mansor M, Chinna K, Mohan S, Karimian H, et al. Glutamine treatment attenuates hyperglycemia-induced mitochondrial stress and apoptosis in umbilical vein endothelial cells. Clinics. 2015;70(8).
11.
Zurück zum Zitat Kumar S, Safi SZ, Qvist R, Ismail IS. Effect of agonists of adenosine receptors on inflammatory markers in human muller cells. Curr Sci. 2014;106(4):582–6. Kumar S, Safi SZ, Qvist R, Ismail IS. Effect of agonists of adenosine receptors on inflammatory markers in human muller cells. Curr Sci. 2014;106(4):582–6.
12.
Zurück zum Zitat Sanghera DK, Blackett PR. Type 2 diabetes genetics: beyond GWAS. J Diabetes Metab. 2012;3(198). Sanghera DK, Blackett PR. Type 2 diabetes genetics: beyond GWAS. J Diabetes Metab. 2012;3(198).
13.
Zurück zum Zitat Zeggini E et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40(5):638–45.CrossRefPubMedPubMedCentral Zeggini E et al. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40(5):638–45.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Ho JS et al. Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population. Diabetes Res Clin Pract. 2012;97(3):483–91.CrossRefPubMed Ho JS et al. Association of the PPARG Pro12Ala polymorphism with type 2 diabetes and incident coronary heart disease in a Hong Kong Chinese population. Diabetes Res Clin Pract. 2012;97(3):483–91.CrossRefPubMed
15.
Zurück zum Zitat Wan J, Xiong S, Chao S, Xiao J, Ma Y, Wang J, et al. PPARγ gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus. Cardiovasc Diabetol. 2010;9(13). Wan J, Xiong S, Chao S, Xiao J, Ma Y, Wang J, et al. PPARγ gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus. Cardiovasc Diabetol. 2010;9(13).
16.
Zurück zum Zitat Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human peroxisome proliferator activated receptor g (hPPARg) gene in diabetic Caucasians: identification of a Pro12Ala PPARg2 missense mutation. Biochem Biophys Res Commun. 1997;241:270–4.CrossRefPubMed Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human peroxisome proliferator activated receptor g (hPPARg) gene in diabetic Caucasians: identification of a Pro12Ala PPARg2 missense mutation. Biochem Biophys Res Commun. 1997;241:270–4.CrossRefPubMed
17.
Zurück zum Zitat Tripathi AK, Shukla S, Dwivedi MK, Tripathi JK, Chauhan UK, Indurkar M, et al. Type 2 diabetes in a central Indian population: association with PPARG2 P121A allele but not ENPP1 K121Q. Advances in Genomics and Genetics. 2013. Tripathi AK, Shukla S, Dwivedi MK, Tripathi JK, Chauhan UK, Indurkar M, et al. Type 2 diabetes in a central Indian population: association with PPARG2 P121A allele but not ENPP1 K121Q. Advances in Genomics and Genetics. 2013.
18.
Zurück zum Zitat Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Pories WJ, Caro JF, et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest. 1997;99(10):2416–22.CrossRefPubMedPubMedCentral Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Pories WJ, Caro JF, et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest. 1997;99(10):2416–22.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Werman A et al. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and −2 isoforms and influence of insulin. J Biol Chem. 1997;272(32):20230–5.CrossRefPubMed Werman A et al. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and −2 isoforms and influence of insulin. J Biol Chem. 1997;272(32):20230–5.CrossRefPubMed
20.
Zurück zum Zitat Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest. 1997;100:530–7.CrossRefPubMedPubMedCentral Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest. 1997;100:530–7.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994;79:1147–56.CrossRefPubMed Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994;79:1147–56.CrossRefPubMed
22.
Zurück zum Zitat Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treatment with troglitazone. N Engl J Med. 1994;331:1188–93.CrossRefPubMed Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treatment with troglitazone. N Engl J Med. 1994;331:1188–93.CrossRefPubMed
23.
Zurück zum Zitat Berger J, Bailey P, Biswas C, Cullinan CA, Doebber TW, Hayes NS, et al. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology. 1996;137:4189–95.PubMed Berger J, Bailey P, Biswas C, Cullinan CA, Doebber TW, Hayes NS, et al. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology. 1996;137:4189–95.PubMed
24.
Zurück zum Zitat Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, et al. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem. 1996;39:665–8.CrossRefPubMed Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, et al. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem. 1996;39:665–8.CrossRefPubMed
25.
Zurück zum Zitat Mukherjee R, Davies PJ, Crombie DL, Bischoff ED, Cesario RM, Jow L, et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature. 1997;386:407–10.CrossRefPubMed Mukherjee R, Davies PJ, Crombie DL, Bischoff ED, Cesario RM, Jow L, et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature. 1997;386:407–10.CrossRefPubMed
26.
Zurück zum Zitat Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26(1):76–80.CrossRefPubMed Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26(1):76–80.CrossRefPubMed
27.
Zurück zum Zitat Rangwala SM, Rhoades B, Shapiro JS, Rich AS, Kim JK, Shulman GI, et al. Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev Cell. 2003;5:657–63.CrossRefPubMed Rangwala SM, Rhoades B, Shapiro JS, Rich AS, Kim JK, Shulman GI, et al. Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev Cell. 2003;5:657–63.CrossRefPubMed
28.
Zurück zum Zitat Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4(4):597–609.CrossRefPubMed Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4(4):597–609.CrossRefPubMed
29.
Zurück zum Zitat Miles PD, Barak Y, He W, Evans RM, Olefsky JM. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest. 2000;105(3):287–92.CrossRefPubMedPubMedCentral Miles PD, Barak Y, He W, Evans RM, Olefsky JM. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest. 2000;105(3):287–92.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem. 2001;276(44):41245–54.CrossRefPubMed Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem. 2001;276(44):41245–54.CrossRefPubMed
31.
Zurück zum Zitat Radha V, Mohan V. Genetic predisposition to type 2 diabetes among Asian Indians. Indian J Med Res. 2007;125:259–74.PubMed Radha V, Mohan V. Genetic predisposition to type 2 diabetes among Asian Indians. Indian J Med Res. 2007;125:259–74.PubMed
32.
Zurück zum Zitat Scott LJ et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316(5829):1341–5.CrossRefPubMedPubMedCentral Scott LJ et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316(5829):1341–5.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Saxena R et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316(5829):1331–6.CrossRefPubMed Saxena R et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316(5829):1331–6.CrossRefPubMed
34.
Zurück zum Zitat Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661–78.CrossRef Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661–78.CrossRef
35.
Zurück zum Zitat Stumvoll M, Häring H. Perspectives in diabetes: the peroxisome proliferator–activated receptor-2 Pro12Ala polymorphism. Diabetes. 2002;51:2341–7.CrossRefPubMed Stumvoll M, Häring H. Perspectives in diabetes: the peroxisome proliferator–activated receptor-2 Pro12Ala polymorphism. Diabetes. 2002;51:2341–7.CrossRefPubMed
36.
Zurück zum Zitat Tripathi AK, Shukla S, Dwivedi MK, Tripathi JK, Chauhan UK, Shukla S, et al. Obesity and ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) polymorphism and their association with pathophysiology diabetes type 2 in Central Indian population. Journal of Diabetes and Endocrinology. 2013;4(2). Tripathi AK, Shukla S, Dwivedi MK, Tripathi JK, Chauhan UK, Shukla S, et al. Obesity and ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) polymorphism and their association with pathophysiology diabetes type 2 in Central Indian population. Journal of Diabetes and Endocrinology. 2013;4(2).
38.
Zurück zum Zitat Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J. Association between peroxisome proliferator–activated receptor haplotypes and the metabolic syndrome in French men and women. Diabetes Care. 2005;54:3043–8.CrossRef Meirhaeghe A, Cottel D, Amouyel P, Dallongeville J. Association between peroxisome proliferator–activated receptor haplotypes and the metabolic syndrome in French men and women. Diabetes Care. 2005;54:3043–8.CrossRef
39.
Zurück zum Zitat Sanghera DK et al. PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor. Metabolism. 2010;59(4):492–501.CrossRefPubMed Sanghera DK et al. PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor. Metabolism. 2010;59(4):492–501.CrossRefPubMed
40.
Zurück zum Zitat Ereqat S et al. Impact of the Pro12Ala polymorphism of the PPAR-gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients. PPAR Res. 2009;2009:874126.CrossRefPubMedPubMedCentral Ereqat S et al. Impact of the Pro12Ala polymorphism of the PPAR-gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients. PPAR Res. 2009;2009:874126.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Pattanayak AK, Bankura B, Balmiki N, Das TK, Chowdhury S, Das M. Role of peroxisome proliferator-activated receptor gamma gene polymorphisms in type 2 diabetes mellitus patients of West Bengal, India. Diabetes Invest. 2014;5:188–91.CrossRef Pattanayak AK, Bankura B, Balmiki N, Das TK, Chowdhury S, Das M. Role of peroxisome proliferator-activated receptor gamma gene polymorphisms in type 2 diabetes mellitus patients of West Bengal, India. Diabetes Invest. 2014;5:188–91.CrossRef
42.
Zurück zum Zitat Kawasaki I et al. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese type 2 diabetic and healthy subjects. Osaka City Med J. 2002;48(1):23–8.PubMed Kawasaki I et al. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese type 2 diabetic and healthy subjects. Osaka City Med J. 2002;48(1):23–8.PubMed
43.
Zurück zum Zitat Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, et al. The peroxisome poliferator–activated receptor-g2 Pro12Ala variant: association with type 2 diabetes and trait differences. Diabetes. 2001;50:886–90.CrossRefPubMed Douglas JA, Erdos MR, Watanabe RM, Braun A, Johnston CL, Oeth P, et al. The peroxisome poliferator–activated receptor-g2 Pro12Ala variant: association with type 2 diabetes and trait differences. Diabetes. 2001;50:886–90.CrossRefPubMed
44.
Zurück zum Zitat Sanghera DK, Ortega L, Han S, Singh J, Ralhan SK, Wander GS, et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet. 2008;9(59):1–9. Sanghera DK, Ortega L, Han S, Singh J, Ralhan SK, Wander GS, et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet. 2008;9(59):1–9.
45.
Zurück zum Zitat Kooner JS et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011;43(10):984–9.CrossRefPubMedPubMedCentral Kooner JS et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet. 2011;43(10):984–9.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Hara K et al. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun. 2000;271(1):212–6.CrossRefPubMed Hara K et al. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun. 2000;271(1):212–6.CrossRefPubMed
47.
Zurück zum Zitat Ek J et al. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant Caucasians. Diabetologia. 2001;44(9):1170–6.CrossRefPubMed Ek J et al. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant Caucasians. Diabetologia. 2001;44(9):1170–6.CrossRefPubMed
48.
Zurück zum Zitat Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76–80.CrossRefPubMed Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76–80.CrossRefPubMed
49.
Zurück zum Zitat Deeb SS et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20(3):284–7.CrossRefPubMed Deeb SS et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20(3):284–7.CrossRefPubMed
50.
Zurück zum Zitat González Sánchez JL, Serrano Ríos M, Fernández Perez C, Laakso M, Martínez Larrad MT. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol. 2002;147:495–501.CrossRefPubMed González Sánchez JL, Serrano Ríos M, Fernández Perez C, Laakso M, Martínez Larrad MT. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population. Eur J Endocrinol. 2002;147:495–501.CrossRefPubMed
51.
Zurück zum Zitat Frederiksen L, Brødbaek K, Fenger M, Jørgensen T, Borch-Johnsen K, Madsbad S, et al. Studies of the Pro12Ala polymorphism of the PPAR-γ gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab. 2002;87(8). Frederiksen L, Brødbaek K, Fenger M, Jørgensen T, Borch-Johnsen K, Madsbad S, et al. Studies of the Pro12Ala polymorphism of the PPAR-γ gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome. J Clin Endocrinol Metab. 2002;87(8).
52.
Zurück zum Zitat Motavallian A, Andalib S, Vaseghi G, Mirmohammad-Sadeghi H, Amini M. Association between PRO12ALA polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in Iranian patients. Indian J Hum Genet. 2013;19(2):239–44.CrossRefPubMedPubMedCentral Motavallian A, Andalib S, Vaseghi G, Mirmohammad-Sadeghi H, Amini M. Association between PRO12ALA polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in Iranian patients. Indian J Hum Genet. 2013;19(2):239–44.CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Oh EY, Min KM, Chung JH, Min YK, Lee MS, Kim KW, et al. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-γ2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab. 1999;85(5):1801–4. Oh EY, Min KM, Chung JH, Min YK, Lee MS, Kim KW, et al. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-γ2 in Korean diabetic and obese subjects. J Clin Endocrinol Metab. 1999;85(5):1801–4.
54.
Zurück zum Zitat Radha V et al. Role of genetic polymorphism peroxisome proliferator-activated receptor-2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: evidence for heterogeneity. Diabetes Care. 2006;29(5):1046–51.CrossRefPubMed Radha V et al. Role of genetic polymorphism peroxisome proliferator-activated receptor-2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: evidence for heterogeneity. Diabetes Care. 2006;29(5):1046–51.CrossRefPubMed
55.
Zurück zum Zitat Hegele RA et al. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab. 2000;85(5):2014–9.PubMed Hegele RA et al. Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab. 2000;85(5):2014–9.PubMed
56.
Zurück zum Zitat Mori H et al. The Pro12 → Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes. 2001;50(4):891–4.CrossRefPubMed Mori H et al. The Pro12 → Ala substitution in PPAR-γ is associated with resistance to development of diabetes in the general population: possible involvement in impairment of insulin secretion in individuals with type 2 diabetes. Diabetes. 2001;50(4):891–4.CrossRefPubMed
57.
Zurück zum Zitat Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and association in four case–control studies. Am J Hum Genet. 2002;71(2):304–11.CrossRefPubMedPubMedCentral Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and association in four case–control studies. Am J Hum Genet. 2002;71(2):304–11.CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Lindi VI, Uusitupa MI, Lindström J, Louheranta A, Eriksson JG, Valle TT, et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish diabetes prevention study. Diabetes. 2002;51:2581–6.CrossRefPubMed Lindi VI, Uusitupa MI, Lindström J, Louheranta A, Eriksson JG, Valle TT, et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish diabetes prevention study. Diabetes. 2002;51:2581–6.CrossRefPubMed
59.
Zurück zum Zitat Mancini FP et al. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes. 1999;48(7):1466–8.CrossRefPubMed Mancini FP et al. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes. 1999;48(7):1466–8.CrossRefPubMed
60.
Zurück zum Zitat Stumvoll M et al. Pro12Ala polymorphism in the peroxisome proliferator–activated receptor-g2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes. 2001;50:876–81.CrossRefPubMed Stumvoll M et al. Pro12Ala polymorphism in the peroxisome proliferator–activated receptor-g2 gene is associated with increased antilipolytic insulin sensitivity. Diabetes. 2001;50:876–81.CrossRefPubMed
61.
Zurück zum Zitat Memisoglu A, Hu FB, Hankinson SE, Liu S, Meigs JB, Altshuler DM, et al. Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes. Diabetes Care. 2003;26(10):2915–7.CrossRefPubMed Memisoglu A, Hu FB, Hankinson SE, Liu S, Meigs JB, Altshuler DM, et al. Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes. Diabetes Care. 2003;26(10):2915–7.CrossRefPubMed
62.
Zurück zum Zitat Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E. Peroxisome proliferator-activated receptor-g2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes. The Berlin diabetes mellitus (BeDiaM) study. Diabetes. 2002;51:2653–7.CrossRefPubMed Herrmann SM, Ringel J, Wang JG, Staessen JA, Brand E. Peroxisome proliferator-activated receptor-g2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes. The Berlin diabetes mellitus (BeDiaM) study. Diabetes. 2002;51:2653–7.CrossRefPubMed
63.
Zurück zum Zitat Caramori ML, Canani LH, Costa LA, Gross JL. The human peroxisome proliferator-activated receptor-g2 (PPAR-g2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes. Diabetes. 2003;52:3010–3.CrossRefPubMed Caramori ML, Canani LH, Costa LA, Gross JL. The human peroxisome proliferator-activated receptor-g2 (PPAR-g2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes. Diabetes. 2003;52:3010–3.CrossRefPubMed
64.
Zurück zum Zitat Ringel J, Engeli S, Distler A, Sharma AM. Pro12 Ala minsense mutation of the peroxisone proliferator activated receptor γ and diabetes mellitus. Biochem Biophys Res Commun. 1999;254:450–3.CrossRefPubMed Ringel J, Engeli S, Distler A, Sharma AM. Pro12 Ala minsense mutation of the peroxisone proliferator activated receptor γ and diabetes mellitus. Biochem Biophys Res Commun. 1999;254:450–3.CrossRefPubMed
65.
Zurück zum Zitat Soriguer F, Morcillo S, Cardona F, et al. Pro 12 Ala polymorphism of PPAR gamma 2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J Nutr. 2006;136:2325–30.PubMed Soriguer F, Morcillo S, Cardona F, et al. Pro 12 Ala polymorphism of PPAR gamma 2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J Nutr. 2006;136:2325–30.PubMed
66.
Zurück zum Zitat Rosa G, Huguenin GVB. The Ala allele in the PPAR-c2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects. Br J Nutr. 2010;104(488):488–97.PubMed Rosa G, Huguenin GVB. The Ala allele in the PPAR-c2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects. Br J Nutr. 2010;104(488):488–97.PubMed
67.
Zurück zum Zitat Wang X et al. The association between the Pro12Ala variant in the PPARgamma2 gene and type 2 diabetes mellitus and obesity in a Chinese population. PLoS One. 2013;8(8), e71985.CrossRefPubMedPubMedCentral Wang X et al. The association between the Pro12Ala variant in the PPARgamma2 gene and type 2 diabetes mellitus and obesity in a Chinese population. PLoS One. 2013;8(8), e71985.CrossRefPubMedPubMedCentral
68.
Zurück zum Zitat Rhee EJ et al. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-γ gene on metabolic syndrome. Arch Med Res. 2006;37(1):86–94.CrossRefPubMed Rhee EJ et al. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-γ gene on metabolic syndrome. Arch Med Res. 2006;37(1):86–94.CrossRefPubMed
69.
Zurück zum Zitat Kao WH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the atherosclerosis risk in communities study. Diabetes. 2003;52(6):1568.CrossRefPubMed Kao WH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the atherosclerosis risk in communities study. Diabetes. 2003;52(6):1568.CrossRefPubMed
70.
Zurück zum Zitat Meshkani R et al. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPARγ-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population. Clin Chem Lab Med. 2007;45:477.CrossRefPubMed Meshkani R et al. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPARγ-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population. Clin Chem Lab Med. 2007;45:477.CrossRefPubMed
Metadaten
Titel
Role of PPARG (Pro12Ala) in Malaysian type 2 diabetes mellitus patients
verfasst von
Darishiani Paramasivam
Sher Zaman Safi
Rajes Qvist
Imran Bin Zainal Abidin
Noran Naqiah Mohd Hairi
Karuthan Chinna
Publikationsdatum
15.01.2016
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 4/2016
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0462-5

Weitere Artikel der Ausgabe 4/2016

International Journal of Diabetes in Developing Countries 4/2016 Zur Ausgabe